AFMD - Affimed N.V. (AFMD) CEO Adi Hoess on Q2 2021 Results - Earnings Call Transcript

Affimed N.V. (AFMD) Q2 2021 Earnings Conference Call September 8, 2021 08:30 ET Company Participants Alex Fudukidis - Head, Investor Relations Adi Hoess - Chief Executive Officer Andreas Harstrick - Chief Medical Officer Arndt Schottelius - Chief Scientific Officer Wolfgang Fischer - Chief Operating Officer Angus Smith - Chief Financial Officer Conference Call Participants Daina Graybosch - SVB Leerink Maury Raycroft - Jefferies Nick Abbott - Wells Fargo Yale Jen - Laidlaw Presentation Operator Good day and welcome to Affimed’s Second Quarter 2021 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, today’s conference call is being recorded. I’d now like to introduce your host for today’s conference call, Alex Fudukidis, Head of Investor Relations at Affimed. Please go ahead. Alex Fudukidis Thank you, Liz. I would like to also welcome you all for joining us today for our second quarter 2021 results and operational update call.

For further details see:

Affimed N.V. (AFMD) CEO Adi Hoess on Q2 2021 Results - Earnings Call Transcript